Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...

A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers-which affect parts of the body involved in reproduction and excretion-in middle aged adults, suggests ...

Fasting and ketogenic diets were found to benefit blood fats, weight, and blood pressure in MS, but did not reduce brain ...

TransMedics' growth is set to remain robust over the next 12 months, supported by its heart and lung clinical trials. Click ...

A drug called riluzole, commonly used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases, could ...

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart failure with preserved ejection fraction.The study investigated the effectiveness ...

One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage ...

Drs Ryan Ungaro and Laurie Keefer discuss brain-gut behavior therapy and the potential for combining it with biologic ...

Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and ...

Wilmington-based Predicate AI Labs Inc. has entered a collaboration with the Mayo Clinic to advance the early detection of ...

A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.

Researchers have identified several modifiable risk factors that can help prevent the potentially life-threatening condition.